...
首页> 外文期刊>AIDS Research and Human Retroviruses >Going Beyond Giving Antiretroviral Therapy: Multimorbidity in Older People Aging with HIV in Nigeria
【24h】

Going Beyond Giving Antiretroviral Therapy: Multimorbidity in Older People Aging with HIV in Nigeria

机译:除了给予抗逆转录病毒治疗:老年人在尼日利亚艾滋病毒衰老的多元化性

获取原文
获取原文并翻译 | 示例

摘要

“Graying of HIV epidemic” is observed globally, as people living with HIV (PLWH) are aging, due to effectiveness of antiretrovirals. The normal aging processes and HIV-induced immune dysfunction, are potential mechanisms, driving multimorbidity (MM) in PLWH. MM is the concurrent presence of two or more diseases in a single individual. Aging PLWH, are at increased risk of acute and chronic morbidities compared with counterpart without HIV. Despite increasing concern in Nigeria, research on correlates of MM in aging PLWH is lagging. This was a comparative study, of ≥60 years of age, age-matched (±5 years) HIV-positive and HIV-negative patients. Patients were recruited, from the Infectious Disease Institute and Geriatric clinics of the University College Hospital, Ibadan, Nigeria, between April and June 2018. MM was defined as the occurrence of more than two morbidities in an individual, and it was considered acute, when within 30 days and chronic, when above 3-months duration. Data analysis was done using SPSS 23. We studied 186 individuals (62 HIV-positive and 124 HIV-negative). The PLWH had lower mean age (63.9 vs. 68.1 years, p?=?.00, t?=?5.68), more chronic MM (2.0 vs. 1.3, p?=?.004, t?=?2.970), which occurred earlier (4.7 vs. 9.6 years, p?=?.003, t?=?3.05), more overall MM (3.6 vs. 2.8, p?=?.015, t?=?2.448), and lower quality of life (82.7 vs. 86.2, p?=?.002, t?=?3.130). Risk estimates for “any” MM revealed the odds are in favor of the older PLWH [69.4% vs. 46.8%, p?=?.004, odds ratio?=?0.388 (95% confidence interval?=?0.204–0.740)]. Logistic regression revealed, age >64 years, higher total body fat, lower nadir CD4 counts, and longer duration of HIV infection, were significantly associated with MM in aging PLWH (p?=?.019). Older individuals with HIV on antiretrovirals in Ibadan, had a significantly greater burden of MM compared with those without HIV. HIV treatment programs in Nigeria will need to adapt a comprehensive health care plan for aging PLWH.
机译:在全球范围内观察到“艾滋病毒流行病的灰色”,因为患有艾滋病毒(PLWH)的人们患者,由于抗逆转录病毒的有效性,患有艾滋病毒(PLWH)。正常的老化方法和艾滋病毒诱导的免疫功能障碍是潜在的机制,在PLWH中驱动多重药物(mm)。 MM是单个个体中两种或多种疾病的同时存在。与没有艾滋病毒的对应物相比,衰老PLWH,急性和慢性生病性的风险增加。尽管尼日利亚越来越多,但对老化PLWH的MM相关的研究是滞后的。这是一个比较研究,≥60岁,年龄匹配(±5年)艾滋病毒阳性和HIV阴性患者。从2018年4月和6月在2018年4月和6月之间,来自大学学院医院的传染病学院和老年人诊所的招聘患者,被定义为个体中超过两个病态的发生,而且何时被认为是急性的在30天内和慢性,当以上3个月的持续时间。使用SPSS 23进行数据分析。我们研究了186名人(62个HIV阳性和124个HIV阴性)。 PLWH的平均年龄较低(63.9与68.1岁,P?00,T?5.68),更慢性mm(2.0与1.3,p?= 004,t?=?2.970),早期发生(4.7与9.6岁,p?= 003,t?= 3.05),更全面的mm(3.6与2.8,p?= 015,t?=?2.448),更低生命(82.7与86.2,p?=α.002,T?= 3.130)。 “任何”MM的风险估计显示赔率有利于较旧的PLWH [69.4%与46.8%,p?=α.004,差异Δ=?0.388(95%置信区间?=?0.204-0.740) ]。 Logistic回归揭示,年龄> 64岁,较高的体脂,较低的Nadir CD4计数,以及较长的HIV感染持续时间,与衰老PLWH(P?= 019)显着相关与没有艾滋病毒的人相比,患有艾滋病毒的抗逆转录病毒患者的艾滋病病毒性尼日利亚的艾滋病毒治疗方案需要适应旧卫生保健计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号